Your session is about to expire
← Back to Search
Procedure
Nasal Stimulation for Dry Eye Syndrome
N/A
Recruiting
Research Sponsored by Alcon Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Within the last 6 months, have used, or desired to use artificial tears for dry eye symptoms
Within the last 12 months, have a previous history of dry eye disease, either clinician diagnosed or patient reported
Must not have
Current evidence of any clinically significant ophthalmic disease other than dry eye (for example, glaucoma or macular degeneration)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1 pre-stimulation (baseline); day 1 immediately post-stimulation
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to measure how much tears are produced when the inside of the nose is stimulated with a cotton swab in people with dry eye disease.
Who is the study for?
This trial is for individuals who have had dry eye disease within the last year, whether diagnosed by a doctor or self-reported. Participants should have used or wanted to use artificial tears in the past 6 months and must have decent vision with correction. They need to be generally healthy based on medical history and eye exams, and able to follow study instructions.
What is being tested?
The study aims to assess how well reflex tear production works after stimulating the nose with a cotton swab in people suffering from dry eye syndrome. It's designed to see if this method can help measure tear production effectively.
What are the potential side effects?
Since this intervention involves only nasal stimulation using a cotton swab, side effects are expected to be minimal but may include temporary discomfort or sneezing during the procedure.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have used or wanted to use artificial tears for dry eyes in the last 6 months.
Select...
I have had dry eye disease in the past year.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I do not have any serious eye conditions besides dry eye.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 1 pre-stimulation (baseline); day 1 immediately post-stimulation
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1 pre-stimulation (baseline); day 1 immediately post-stimulation
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change from baseline in TMH immediately following stimulation
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Nasal StimulationExperimental Treatment1 Intervention
The Investigator will insert cotton swabs into both nostrils of the subject and gently probe the nasal middle cavities. Stimulation will stop once visible and obvious reflex tearing has begun.
Find a Location
Who is running the clinical trial?
Alcon ResearchLead Sponsor
732 Previous Clinical Trials
128,779 Total Patients Enrolled
Clinical Trial Lead, PharmaStudy DirectorAlcon Research, LLC
3 Previous Clinical Trials
600 Total Patients Enrolled